Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04676360
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2020-12-15
Brief Title:
Belantamab Mafodotin In Plasmablastic Lymphoma ALK Large B-Cell Lymphoma
Sponsor:
Jacob Soumerai MD
Organization:
Massachusetts General Hospital
Organization Data
Organization:
Massachusetts General Hospital
Class:
OTHER
Study ID:
20-404
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jacob Soumerai MD
Lead Sponsor Class:
OTHER
Responsible Party:
Jacob Soumerai MD
Responsible Party Title:
Sponsor Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Massachusetts General Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |